EUVIMEDEUVIMED entdecken
Crossref

Comparing Genomic Landscapes of Oral and Cutaneous Squamous Cell Carcinoma of the Head and Neck: Quest for Novel Diagnostic Markers

Ruta Gupta, Dario Strbenac, Laveniya Satgunaseelan, Veronica Ka-Yan Cheung, Harini Narayanappa, Bruce Ashford, Jenny Mitchell, Amarinder Thind, Carsten E Palme, Sydney Ch'ng, Tsu-Hui Hubert Low, James Wykes und 5 weitere

Modern Pathology · 2023

DOI: 10.1016/j.modpat.2023.100190 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Pathology, 2023. Verfasst von Ruta Gupta und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Tissue Pathology and Diagnostic Oncology, NSW Health Pathology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia; Sydne…. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Mouth Neoplasms, Skin Neoplasms, Head and Neck Neoplasms. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 44 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Squamous cell carcinoma is the most common head and neck malignancy arising from the oral mucosa and the skin. The histologic and immunohistochemical features of oral squamous cell carcinoma (OSCC) and head and neck cutaneous squamous cell carcinoma (HNcSCC) are similar, making it difficult to identify the primary site in cases of metastases. With the advent of immunotherapy, reliable distinction of OSCC and HNcSCC at metastatic sites has important treatment and prognostic implications. Here, we investigate and compare the genomic landscape of OSCC and HNcSCC to identify diagnostically useful biomarkers. Whole-genome sequencing data from 57 OSCC and 41 HNcSCC patients were obtained for tumor and matched normal samples. Tumor mutation burden (TMB), Catalogue of Somatic Mutations in Cancer (COSMIC) mutational signatures, frequent chromosomal alterations, somatic single nucleotide, and copy number variations were analyzed. The median TMB of 3.75 in primary OSCC was significantly lower (P < .001) than that of 147.51 mutations/Mb in primary HNcSCC. The COSMIC mutation signatures were significantly different (P < .001) between OSCC and HNcSCC. OSCC showed COSMIC single-base substitution (SBS) mutation signature 1 and AID/APOBEC activity-associated signature 2 and/or 13. All except 1 HNcSCC from hair-bearing scalp showed UV damage-associated COSMIC SBS mutation signature 7. Both OSCC and HNcSCC demonstrated a predominance of tumor suppressor gene mutations, predominantly TP53. The most frequently mutated oncogenes were PIK3CA and MUC4 in OSCC and HNcSCC, respectively. The metastases of OSCC and HNcSCC demonstrated TMB and COSMIC SBS mutation signatures similar to their primary counterparts. The combination of high TMB and UV signature in a metastatic keratinizing squamous cell carcinoma suggests HNcSCC as the primary site and may also facilitate decisions regarding immunotherapy. HNcSCC and OSCC show distinct genomic profiles despite histologic and immunohistochemical similarities. Their genomic characteristics may underlie differences in behavior and guide treatment decisions in recurrent and metastatic settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Squamous CellMouth NeoplasmsSkin NeoplasmsHead and Neck NeoplasmsHumansSquamous Cell Carcinoma of Head and NeckDNA Copy Number VariationsMutationGenomicsBiomarkers, Tumor

Stichwörter der Autor:innen

cutaneoushead and neckkeratinizing squamous cell carcinomamutation signaturetumor mutation burdenwhole-genome sequencing

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Tissue Pathology and Diagnostic Oncology, NSW Health Pathology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia; Sydney Medical School, Faculty of Medicine and Health Sciences, The Univers…
  • School of Mathematics and Statistics, The University of Sydney, Sydney, New South Wales, Australia; Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia.
  • Department of Tissue Pathology and Diagnostic Oncology, NSW Health Pathology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
  • Graduate School of Medicine, University of Wollongong, Wollongong, New South Wales, Australia; Illawarra Health and Medical Research Institute, Wollongong, New South Wales, Australia; Illawarra Shoalhaven Local Health D…
  • Graduate School of Medicine, University of Wollongong, Wollongong, New South Wales, Australia; Illawarra Health and Medical Research Institute, Wollongong, New South Wales, Australia.
  • Sydney Medical School, Faculty of Medicine and Health Sciences, The University of Sydney, Sydney, New South Wales, Australia; Department of Head and Neck Surgery, Sydney Head and Neck Cancer Institute, Chris O'Brien Lif…

Zitieren

APA

Gupta, R., Strbenac, D., Satgunaseelan, L., Cheung, V. K., Narayanappa, H., Ashford, B., Mitchell, J., Thind, A., Palme, C. E., Ch'ng, S., Low, T. H., Wykes, J., Willet, C. E., Chew, T., Yang, J., Ranson, M., & Clark, J. R. (2023). Comparing Genomic Landscapes of Oral and Cutaneous Squamous Cell Carcinoma of the Head and Neck: Quest for Novel Diagnostic Markers. Modern Pathology. https://doi.org/10.1016/j.modpat.2023.100190

Vancouver

Gupta R, Strbenac D, Satgunaseelan L, Cheung VK, Narayanappa H, Ashford B, et al. Comparing Genomic Landscapes of Oral and Cutaneous Squamous Cell Carcinoma of the Head and Neck: Quest for Novel Diagnostic Markers. Modern Pathology. 2023. doi:10.1016/j.modpat.2023.100190

BibTeX
@article{Gupta2023,
  author = {Gupta, Ruta and Strbenac, Dario and Satgunaseelan, Laveniya and Cheung, Veronica Ka-Yan and Narayanappa, Harini and Ashford, Bruce and Mitchell, Jenny and Thind, Amarinder and Palme, Carsten E and Ch'ng, Sydney and Low, Tsu-Hui Hubert and Wykes, James and Willet, Cali E and Chew, Tracy and Yang, Jean and Ranson, Marie and Clark, Jonathan R},
  title = {Comparing Genomic Landscapes of Oral and Cutaneous Squamous Cell Carcinoma of the Head and Neck: Quest for Novel Diagnostic Markers},
  journal = {Modern Pathology},
  year = {2023},
  doi = {10.1016/j.modpat.2023.100190}
}
Kostenlos starten →